ATE547409T1 - Verbessertes verfahren zur herstellung von letrozol und zwischenprodukten davon - Google Patents

Verbessertes verfahren zur herstellung von letrozol und zwischenprodukten davon

Info

Publication number
ATE547409T1
ATE547409T1 AT08702736T AT08702736T ATE547409T1 AT E547409 T1 ATE547409 T1 AT E547409T1 AT 08702736 T AT08702736 T AT 08702736T AT 08702736 T AT08702736 T AT 08702736T AT E547409 T1 ATE547409 T1 AT E547409T1
Authority
AT
Austria
Prior art keywords
letrozole
producing
improved method
intermediate products
formula
Prior art date
Application number
AT08702736T
Other languages
English (en)
Inventor
Vimal Shrawat
Jai Singh
Rajesh Nautiyal
Original Assignee
Fresenius Kabi Oncology Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fresenius Kabi Oncology Ltd filed Critical Fresenius Kabi Oncology Ltd
Application granted granted Critical
Publication of ATE547409T1 publication Critical patent/ATE547409T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
AT08702736T 2007-11-28 2008-01-16 Verbessertes verfahren zur herstellung von letrozol und zwischenprodukten davon ATE547409T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IN2479DE2007 2007-11-28
PCT/IN2008/000024 WO2009069140A1 (en) 2007-11-28 2008-01-16 An improved process for preparation of letrozole and its intermediates

Publications (1)

Publication Number Publication Date
ATE547409T1 true ATE547409T1 (de) 2012-03-15

Family

ID=39651226

Family Applications (1)

Application Number Title Priority Date Filing Date
AT08702736T ATE547409T1 (de) 2007-11-28 2008-01-16 Verbessertes verfahren zur herstellung von letrozol und zwischenprodukten davon

Country Status (4)

Country Link
US (1) US8198460B2 (de)
EP (1) EP2212301B1 (de)
AT (1) ATE547409T1 (de)
WO (1) WO2009069140A1 (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ607428A (en) 2010-08-27 2015-10-30 Generics Uk Ltd Pure intermediate for preparing letrozole
BR112018010988B1 (pt) 2015-12-18 2022-01-18 BASF Agro B.V. Métodos para obtenção e preparação de 2-[4-(4- clorofenoxi)-2-(trifluorometil)fenil]-1- (1,2,4-triazol-1- il)propan-2-ol
TWI793165B (zh) 2017-09-11 2023-02-21 美商阿托薩醫療公司 製造及使用因多昔芬(endoxifen)之方法
MX2022000203A (es) 2019-07-03 2022-03-22 Atossa Therapeutics Inc Composiciones de liberacion sostenida de endoxifeno.

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5352795A (en) * 1986-03-07 1994-10-04 Ciba-Geigy Corporation Alpha-heterocycle substituted tolunitriles
US4978672A (en) 1986-03-07 1990-12-18 Ciba-Geigy Corporation Alpha-heterocyclc substituted tolunitriles
WO2004076409A2 (en) * 2003-02-06 2004-09-10 Sun Pharmaceutical Industries Limited Regiospecific process for the preparation of 4-[1- (4-cyanophenyl)-1-(1,2,4-triazol-1-yl)methyl]benzonitrile
WO2005047269A1 (en) 2003-11-14 2005-05-26 Natco Pharma Limited A method for the separation of the letrozole precursor 4-‘1-(1,2,4-triazolyl) methyl!benzonitrile from its 1,3,4-triazolyl isomer
US20050209294A1 (en) 2004-03-17 2005-09-22 Wadhwa Lalit K Process for producing 4-(1H-1,2,4-triazol-1-ylmethyl)benzonitrile
WO2007005496A1 (en) * 2005-06-30 2007-01-11 Zibra, Llc Hand-held painting tool with paint reservoir
BRPI0605907A2 (pt) 2005-07-06 2009-05-26 Sicor Inc processo aperfeiçoado para a preparação de letrozol
GT200600397A (es) * 2005-09-07 2007-08-28 Formulas topicas conteniendo o-desmetil venlafaxina (odv) o sus sales
WO2007039912A1 (en) 2005-10-05 2007-04-12 Usv Limited A one pot process for the preparation of 4-[1-cyanophenyl)-1-(1,2,4-triazol-1-yl)methyl]benzonitrile
EP1945618A2 (de) * 2005-10-20 2008-07-23 Cadila Healthcare Ltd. Verfahren zur herstellung von letrozol
US7518236B2 (en) * 2005-10-26 2009-04-14 General Electric Company Power circuit package and fabrication method
US20070100149A1 (en) 2005-11-02 2007-05-03 Palle Venkata Raghavendra A Process for preparing letrozole
US7465749B2 (en) 2005-11-14 2008-12-16 Chemagis, Ltd. Letrozole purification process
US7538230B2 (en) 2005-11-14 2009-05-26 Chemagis Ltd. Letrozole production process
WO2007074474A1 (en) 2005-12-27 2007-07-05 Dabur Pharma Limited Novel intermediates for preparation of letrozole
WO2007090464A1 (en) 2006-02-08 2007-08-16 Solmag S.P.A. Process for preparing letrozole
GB2450268B (en) * 2006-03-17 2011-01-12 Cipla Ltd Synthesis of 4-[1-(4-cyano phenyl)-1-(1,2,4-triazol-1-yl)methyl]benzonitrile and 4-[1-(1,2,4-triazol-1-yl)methyl]benzonitrile intermediate

Also Published As

Publication number Publication date
WO2009069140A1 (en) 2009-06-04
EP2212301B1 (de) 2012-02-29
EP2212301A1 (de) 2010-08-04
US20100234617A1 (en) 2010-09-16
US8198460B2 (en) 2012-06-12

Similar Documents

Publication Publication Date Title
NZ612119A (en) Use of sigma ligands in bone cancer pain
JO2894B1 (en) Salt and new amorphous images
UA101036C2 (en) Substituted 1-(diazinyl) pyrazole-4-yl-acetic acids
BR112015001608A2 (pt) inibidor lfa-1 e polimorfo do mesmo
EA202091893A1 (ru) Новые кристаллические формы
EA201100094A1 (ru) Тиадиазолилоксифениламидины и их применение в качестве фунгицидов
NO20070368L (no) Virale polymeraseinhibitorer
BRPI0922457A2 (pt) forma polimórfica de ácido 1-(4-{1-[(e)-4-ciclo-hexil-3-trifluormetil-benziloxi-imino]-etil)-2-etil-benzil)-azetidino-3-carboxílico"
EA200901514A1 (ru) Новая сольватная и кристаллическая форма производных карбамоилциклогексана
MX385586B (es) Composiciones que comprenden 2-((1-(2(4-fluorofenil)-2-oxoetil) piperidin-4-il)metil)isoindolin-1-ona para tratar la esquizofrenia.
MY150280A (en) Process of preparing derivatives of 1-(2-halobiphenyl-4-yl)-cyclopropanecarboxylic acid
DE602008001725D1 (de) 1-(1-benzylpiperidin-4-yl)benzimidazol-5-carbonsäurederivate zur behandlung von diabetes mellitus
MX2012005329A (es) Compuestos benzoimidazolicos y sus usos.
CY1118173T1 (el) 5-[(3,3,3-τριφθορο-2-υδροξυ-1-αρυλπροπυλ)αμινο]-1h-κινολιν-2-ονες, μια διεργασια για την παραγωγη τους και η χρηση τους ως αντι-φλεγμονωδων παραγοντων
CY1112520T1 (el) Βενζυλαμινες, μια διαδικασια για την παραγωγη τους και η χρηση τους ως αντι-φλεγμονωδεις παραγοντες
ATE440833T1 (de) Antithrombotische diamide
IN2012DN01273A (de)
CY1117397T1 (el) Παραγωγα 3-ετεροαρουλαμινο-προπιονικου οξεος και χρηση τους ως φαρμακευτικα
CO6361988A2 (es) Forma cristalina de un compuesto de 4-[2-(2-fluorofenoximetil)fenil]piperidina.
CY1118844T1 (el) Υποκατεστημενα παραγωγα 3-ετεροαροϋλαμινο-προπιονικου οξεος και χρηση τους ως φαρμακευτικα
EA201100696A1 (ru) 1-(арилсульфонил)-4-(пиперазин-1-ил)-1h-бензимидазолы в качестве лигандов 5-гидрокситриптамина-6
ATE547409T1 (de) Verbessertes verfahren zur herstellung von letrozol und zwischenprodukten davon
DE502004008871D1 (de) Antiandrogene pyrrolidine mit tumorhemmender wirksamkeit
DE502007003531D1 (de) Verfahren zum herstellen von alkylaniliden aus halogenbenzolderivaten
CY1116739T1 (el) Μεθοδος συνθεσης και κρυσταλλικη μορφη του υδροχλωρικου 4-{3-[cis-εξαϋδροκυκλοπεντα[c]πυρρολ-2(1η)-υλ] προποξυ} βενζαμιδιου καθως και η συνδεομενη ελευθερη βαση και οι φαρμακευτικες συνθεσεις οι οποιες τις περιεχουν